VMP 42130411000001105

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Lacosamide 50mg tablets
BNF code 0408010AHAAAAAA
Virtual Therapeutic Moiety Lacosamide
Date identifier became valid 4 Aug 2023
Previous product identifier 442041004
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Lacosamide
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 50.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Lacosamide 50mg tablets (A A H Pharmaceuticals Ltd)
Lacosamide 50mg tablets (Accord-UK Ltd)
Lacosamide 50mg tablets (Amarox Ltd)
Lacosamide 50mg tablets (Aspire Pharma Ltd)
Lacosamide 50mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Lacosamide 50mg tablets (G.L. Pharma UK Ltd)
Lacosamide 50mg tablets (Macleods Pharma UK Ltd)
Lacosamide 50mg tablets (Milpharm Ltd)
Lacosamide 50mg tablets (Novumgen Ltd)
Lacosamide 50mg tablets (Torrent Pharma (UK) Ltd)
Lacosamide 50mg tablets (Zentiva Pharma UK Ltd)
Vimpat 50mg tablets (CST Pharma Ltd)
Vimpat 50mg tablets (UCB Pharma Ltd)
Virtual Medicinal Product Packs
Lacosamide 50mg tablets 14 tablet
Lacosamide 50mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback